SCHEMBL5453453

SCHEMBL5453453

CCOc1ccccc1NC(=O)Nc1ccc(N2CCN(C(=O)OC(C)(C)C)CC2)nc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.54
MEN1 O00255 3/20 0.54
PABPC1 P11940 1/20 0.54
MAPT P10636 2/20 0.52
TP53 P04637 2/20 0.52
POLB P06746 1/20 0.52
BLM P54132 1/20 0.52
WNT3A P56704 1/20 0.52
DDB1 Q16531 1/20 0.51
CRBN Q96SW2 1/20 0.51
LMNA P02545 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
NPC1 O15118 2/20 0.50
ALDH1A1 P00352 1/20 0.50
CKS1B P61024 2/20 0.49
SKP1 P63208 2/20 0.49
SKP2 Q13309 2/20 0.49
KDM4E B2RXH2 1/20 0.48
RAB9A P51151 2/20 0.48
CASP3 P42574 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5471069 0.91 ALDH1A1 (0.54) KMT2AMEN1PABPC1MAPTWNT3A
SCHEMBL5457902 0.89 WNT3A (0.53) KMT2AMEN1PABPC1MAPTTP53
SCHEMBL5462442 0.89 WNT3A (0.51) KMT2AMEN1PABPC1MAPTTP53
SCHEMBL5465465 0.89 WNT3A (0.51) KMT2AMEN1PABPC1MAPTTP53
SCHEMBL5462055 0.88 NAMPT (0.58) KMT2AMEN1PABPC1MAPTLMNA
SCHEMBL5455802 0.88 KMT2A (0.59) KMT2AMEN1PABPC1MAPTTP53
SCHEMBL5473462 0.87 DGAT1 (0.53) WNT3ADDB1CRBNCKS1BSKP1
SCHEMBL5460864 0.85 WNT3A (0.54) WNT3ADDB1CRBNLMNASMN1; SMN2
SCHEMBL5466937 0.82 KMT2A (0.60) KMT2AMEN1PABPC1MAPTTP53
SCHEMBL5459726 0.80 WNT3A (0.51) KMT2AMEN1MAPTWNT3ADDB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070249620-A1 Urea Derivative SANKYO COMPANY, LIMITED (JP) 2007-10-25 US disclosed
EP-1764360-A1 UREA DERIVATIVE Sankyo Company, Limited (JP) 2007-03-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249620-A1 Urea Derivative UGP2, SLC14A1, DGAT1 KMT2A 1350/4885MEN1 1828/4885PABPC1 3964/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.